Urinary transferrin, high molecular weight proteinuria and the progression of renal disease

被引:1
作者
Mackinnon, B
Shakerdi, L
Deighan, CJ
Fox, JG
O'Reilly, DS
Boulton-Jones, M
机构
[1] Glasgow Royal Infirm, Renal Unit, Glasgow G4 OSF, Lanark, Scotland
[2] Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G4 OSF, Lanark, Scotland
关键词
cholesterol; progression; proteinuria; SDS-PAGE; transferrin;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims. Proteinuria predicts rate of progression in a variety of nephropathies. There is considerable evidence that iron-transferrin is toxic to proximal tubular cells in vitro, and recent clinical work suggests that selectivity of proteinuria influences the outcome of renal disease. The aim of this study was to examine the relationship between the nature of proteinuria and progression of renal disease. Methods. This was a prospective, cross-sectional study in 66 patients with primary glomerulonephritis, diabetic nephropathy and a variety of other renal diseases. Urinary transferrin was measured by sandwich ELISA and correlated with rate of change in estimated creatinine clearance (ECC). Urinary SDS-PAGE was undertaken to divide proteinuria into tertiles according to molecular weight and to quantify the protein in each tertile. The magnitude of each tertile was then correlated with rate of change in ECC over a median period of 20 months. Results. Rate of change of renal function correlated with total proteinuria (r(2) = 18%, p < 0.001) and albuminuria (r(2) = 17%, p < 0.001), but not urinary transferrin (r(2) = 0%, p = 0.235). On univariate analysis high molecular weight proteinuria (r(2) = 21%, p < 0.001), intermediate molecular weight proteinuria (r(2) = 15%, p = 0.001) and low molecular weight proteinuria (r(2) = 10%, p = 0.005) correlated with rate of change in ECC as did total fasting cholesterol (r(2) = 7%, p = 0.003). On multivariate analysis, however, the only independent predictors of rate of change in ECC were high molecular weight proteinuria (r(2) = 19%, p < 0.001), and total fasting cholesterol (r(2) = 5%, p = 0.035). Conclusions. We found no evidence to support the hypothesis that iron-transferrin is important in the development of human renal injury. High molecular weight proteinuria correlates more strongly with rate of progression of renal disease than intermediate molecular weight, low molecular weight or even total proteinuria. This suggests either, that one or more high molecular weight proteins are implicated in causing progressive renal impairment, or that loss of size selectivity at the glomerular basement membrane is associated with accelerated tubulointerstitial damage.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 25 条
  • [1] ROLE OF IRON IN THE TUBULO-INTERSTITIAL INJURY IN NEPHROTOXIC SERUM NEPHRITIS
    ALFREY, AC
    FROMENT, DH
    HAMMOND, WS
    [J]. KIDNEY INTERNATIONAL, 1989, 36 (05) : 753 - 759
  • [2] High proteinuria selectivity index based upon IgM is a strong predictor of poor renal survival in glomerular diseases
    Bakoush, O
    Torffvit, O
    Rippe, B
    Tencer, J
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1357 - 1363
  • [3] Predicting progression in IgA nephropathy
    Bartosik, LP
    Lajoie, G
    Sugar, L
    Cattran, DC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : 728 - 735
  • [4] A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome
    Bazzi, C
    Petrini, C
    Rizza, V
    Arrigo, G
    D'Amico, G
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (04) : 1732 - 1741
  • [5] Urinary excretion of IgG and α1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy
    Bazzi, C
    Petrini, C
    Rizza, V
    Arrigo, G
    Beltrame, A
    Pisano, L
    D'Amico, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (02) : 240 - 248
  • [6] The role of proteinuria in the progression of chronic renal failure
    Burton, C
    Harris, KPG
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (06) : 765 - 775
  • [7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [8] EDDY AA, 1991, AM J PATHOL, V138, P1111
  • [9] Effect of lipid reduction on the progression of renal disease: A meta-analysis
    Fried, LF
    Orchard, TJ
    Kasiske, BL
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (01) : 260 - 269
  • [10] URINARY ALBUMIN, TRANSFERRIN AND IRON EXCRETION IN DIABETIC-PATIENTS
    HOWARD, RL
    BUDDINGTON, B
    ALFREY, AC
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (05) : 923 - 926